Go Pro
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CBY
8134 (CBY.TO)
C$0.00
C$0.00
▼
C$0.00
N/AN/AN/AN/A
OIL
iPath Pure Beta Crude Oil ETN
$3.81
$5.29
$25.31
▼
$39.69
$7.45M0.9640,993 shsN/A
Park National Co. stock logo
PRK
Park National
$207.79
+0.1%		$188.60
$149.06
▼
$215.00
$3.75B0.6991,398 shs48,019 shs
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
C$0.00
C$0.83
▼
C$6.56
C$16.64M4.212,447 shs339 shs
7 Stocks to Buy And Hold Forever Cover
7 Stocks to Buy And Hold Forever

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
OIL
iPath Pure Beta Crude Oil ETN
0.00%0.00%0.00%-86.59%-86.59%
Park National Co. stock logo
PRK
Park National
+0.94%+1.02%+13.22%+26.72%+21.59%
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CBY
8134 (CBY.TO)
C$0.00
C$0.00
▼
C$0.00
N/AN/AN/AN/A
OIL
iPath Pure Beta Crude Oil ETN
$3.81
$5.29
$25.31
▼
$39.69
$7.45M0.9640,993 shsN/A
Park National Co. stock logo
PRK
Park National
$207.79
+0.1%		$188.60
$149.06
▼
$215.00
$3.75B0.6991,398 shs48,019 shs
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
C$0.00
C$0.83
▼
C$6.56
C$16.64M4.212,447 shs339 shs
7 Stocks to Buy And Hold Forever Cover
7 Stocks to Buy And Hold Forever

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
OIL
iPath Pure Beta Crude Oil ETN
0.00%0.00%0.00%-86.59%-86.59%
Park National Co. stock logo
PRK
Park National
+0.94%+1.02%+13.22%+26.72%+21.59%
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CBY
8134 (CBY.TO)
0.00
N/AN/AN/A
OIL
iPath Pure Beta Crude Oil ETN
0.00
N/AN/AN/A
Park National Co. stock logo
PRK
Park National
2.00
Hold$211.001.54% Upside
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest REUN, PRK, OIL, and CBY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/30/2026
Park National Co. stock logo
PRK
Park National
Keefe, Bruyette & Woods logo
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetMarket Perform$180.00 ➝ $205.00
7/29/2026
Park National Co. stock logo
PRK
Park National
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$189.00 ➝ $217.00
7/7/2026
Park National Co. stock logo
PRK
Park National
Raymond James Financial, Inc. logo
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageMarket Perform
6/26/2026
Park National Co. stock logo
PRK
Park National
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$188.00 ➝ $189.00
(Data available from 8/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CBY
8134 (CBY.TO)
N/AN/AN/AN/AN/AN/A
OIL
iPath Pure Beta Crude Oil ETN
N/AN/AN/AN/AN/AN/A
Park National Co. stock logo
PRK
Park National
$623.80M6.02$11.10 per share18.72$76.98 per share2.70
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
C$4.86M0.00N/AN/AC$1.82 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CBY
8134 (CBY.TO)
N/AN/AN/AN/AN/AN/AN/AN/AN/A
OIL
iPath Pure Beta Crude Oil ETN
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Park National Co. stock logo
PRK
Park National
$151.42M$11.1722.3223.01N/A23.46%12.31%1.50%N/A
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
-C$38.10M-C$3.30N/AN/AN/AN/A-86.35%-26.50%N/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
CBY
8134 (CBY.TO)
N/AN/AN/AN/AN/A
OIL
iPath Pure Beta Crude Oil ETN
N/A0.00%N/AN/AN/A
Park National Co. stock logo
PRK
Park National
$4.402.12%+5.26%39.39%8 Years
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
N/AN/AN/AN/AN/A

Latest REUN, PRK, OIL, and CBY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/27/2026
Park National Co. stock logo
PRK
Park National
quarterly$1.102.32%8/21/20268/21/20269/10/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CBY
8134 (CBY.TO)
N/AN/AN/A
OIL
iPath Pure Beta Crude Oil ETN
N/AN/AN/A
Park National Co. stock logo
PRK
Park National
0.15
0.94
0.95
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
N/A
3.52
N/A

Institutional Ownership

CompanyInstitutional Ownership
CBY
8134 (CBY.TO)
N/A
OIL
iPath Pure Beta Crude Oil ETN
N/A
Park National Co. stock logo
PRK
Park National
62.65%
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
50.66%

Insider Ownership

CompanyInsider Ownership
CBY
8134 (CBY.TO)
N/A
OIL
iPath Pure Beta Crude Oil ETN
N/A
Park National Co. stock logo
PRK
Park National
2.20%
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
34.39%
CompanyEmployeesShares OutstandingFree FloatOptionable
CBY
8134 (CBY.TO)
3,030N/AN/ANot Optionable
OIL
iPath Pure Beta Crude Oil ETN
2,0201.96 millionN/ANot Optionable
Park National Co. stock logo
PRK
Park National
1,79018.06 million15.72 millionOptionable
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
19011.72 millionN/ANot Optionable

Recent News About These Companies

Reunion Neuroscience names Sahil Kirpekar as new CEO
June 16, 2026  |  thepharmaletter.comT
Reunion Neuroscience Announces Appointment of Sahil V. Kirpekar, M.D., as President and CEO
June 15, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/reunion-neuroscience-announces-appointment-sahil-113000181.html
Reunion Neuroscience to Present Full Data from RECONNECT Phase 2 Clinical Trial at Upcoming ...
May 12, 2026  |  caledonianrecord.comC
Reunion Neuroscience to Present Full Data from RECONNECT Phase 2 Clinical Trial at Upcoming ASCP and APA Annual Meetings
May 11, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/11/3291844/0/en/reunion-neuroscience-to-present-full-data-from-reconnect-phase-2-clinical-trial-at-upcoming-ascp-and-apa-annual-meetings.html
Luvesilocin Designated Breakthrough Therapy for Postpartum Depression
February 23, 2026  |  empr.comE
U.S. FDA Grants Reunion Neuroscience’s Luvesilocin (RE104) Breakthrough Therapy Designation Status
February 23, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/u-s-fda-grants-reunion-neuroscience-s-luvesilocin-re104-breakthrough-therapy-designation-status-1035854770
Reunion Neuroscience Presents Full Data from RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD) at ACNP Annual Meeting
January 20, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/reunion-neuroscience-presents-full-data-from-reconnect-phase-2-clinical-trial-of-re104-for-the-treatment-of-postpartum-depression-ppd-at-acnp-annual-meeting-1035727120
Reunion Neuroscience expands Series A to $133m after positive trial milestones
September 16, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/reunion-neuroscience-expands-series-133m-153702513.html
AbbVie wagers more than $1B on Gilgamesh’s psychedelic drug
August 25, 2025  |  biopharmadive.comB
Reunion’s psychedelic prodrug reduces postpartum depression symptoms in ph. 2 study
August 18, 2025  |  fiercebiotech.comF
Some postpartum moms are using psychedelics — experts say they may be onto something
August 1, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/some-postpartum-moms-are-using-psychedelics-experts-say-they-may-be-onto-something/ar-AA1JJEo6
ReAlta Life Sciences Names Ellen Lubman as Chief Business Officer
July 28, 2025  |  contractpharma.comC
ReAlta Life Sciences Strengthens Management Team with the Appointment of Biotechnology Business Leader Ellen Lubman, MBA as Chief Business Officer
July 28, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/realta-life-sciences-strengthens-management-120000698.html
Psychedelics may improve psychotherapy outcomes, but obstacles remain
July 3, 2025  |  healio.comH
Shares of psychedelics biotech nearly double on depression data
February 3, 2025  |  biopharmadive.comB
5 More Things We Learned from the "Love Is Blind" Reunion
November 10, 2024  |  psychologytoday.comP
Rx Rundown: AstraZeneca, Danco Laboratories, GSK and more
October 11, 2024  |  mmm-online.comM
Oasis Bringing 2025 Reunion Tour To North America
September 30, 2024  |  spin.comS
Why are so many Roman statues headless?
August 26, 2024  |  msn.comhttps://www.msn.com/en-gb/entertainment/music/why-are-so-many-roman-statues-headless/ar-AA1poGKU
Topics in Integrative Neuroscience
August 23, 2024  |  cambridge.orgC

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Two Very Large Crude Carriers (VLLCs) sailing side by side on open ocean waters, viewed from above.
Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit
By Dan Schmidt | July 19, 2026
Oil refinery at sunset with storage tanks and tanker ship, reflecting strong oil sector demand and recovery outlook.
3 Refiners Benefiting From Oil Volatility and Tight Fuel Supply
By Dan Schmidt | July 29, 2026
A cracked stock chart showing plunging lines above scattered circuit boards, symbolizing a tech-market breakdown.
3 Stocks Standing Out and 2 Losing Momentum as the Tech Rally Cracks
By Bridget Bennett | July 28, 2026
An oil pump jack and drilling rig stand on an arid plain at sunset.
Oil Prices Are Surging and These 4 Stocks Are Cashing In
By Bridget Bennett | July 27, 2026
Chevron logo displayed on a lit sign in front of an oil refinery and storage tanks at sunset.
Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
By Chris Markoch | July 31, 2026

8134 (CBY.TO) TSE:CBY

Canada Bread Company, Limited is a manufacturer and marketer of flour-based products in its various markets, including fresh bread in Canada, frozen partially baked bread in the United States and Canada, specialty bakery products, including fresh pasta and sauces, sweet goods and snack cakes in Canada, and bagels, croissants and other specialty baked goods in the United Kingdom. It operates in two segments: Fresh Bakery business includes pantry breads, rolls, flatbreads, artisan breads, sweet goods and snack cakes sold under a number of brands, including Dempster's, Villaggio, POM, Bon Matin and Ben's, and Frozen Bakery segment consists of frozen par-baked bakery products sold in North America and the United Kingdom bakery business, which specializes in bagels, croissants, and specialty breads. In November 2013, the Company clearanced and closed the sale of Olivieri Foods, to Ebro Foods SA.

iPath Pure Beta Crude Oil ETN NYSEARCA:OIL

$3.81 0.00 (0.00%)
As of 06/10/2026

iPath S&P GSCI Crude Oil Total Return Index ETN is a sub-index of the S&P GSCI Commodity Index. The S&P GSCI Crude Oil Total Return Index reflects the returns that are potentially available through an unleveraged investment in the West Texas Intermediate (WTI) crude oil futures contract plus the Treasury Bill rate of interest that could be earned on funds committed to the trading of the underlying contracts.

Park National stock logo

Park National NYSE:PRK

$207.79 +0.18 (+0.09%)
Closing price 04:00 PM Eastern
Extended Trading
$207.94 +0.16 (+0.07%)
As of 04:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Park National Corporation operates as the bank holding company for Park National Bank that provides commercial banking and trust services in small and medium population areas. The company offers deposits for demand, savings, and time accounts; trust and wealth management services; cash management services; safe deposit operations; electronic funds transfers; Internet and mobile banking solutions with bill pay service; credit cards; and various additional banking-related services. It also provides commercial loans, including financing for industrial and commercial properties, financing for equipment, inventory and accounts receivable, acquisition financing, and commercial leasing, as well as for consumer finance companies; commercial real estate loans comprising mortgage loans to developers and owners of commercial real estate; originates financing leases primarily for the purchase of commercial vehicles, operating/manufacturing equipment, and municipal vehicles/equipment; consumer loans, such as automobile loans; consumer finance services; home equity lines of credit; and residential real estate and construction loans, as well as installment loans and commercial loans. In addition, the company offers aircraft financing services; and ParkDirect, a personal banking application. Park National Corporation was founded in 1908 and is headquartered in Newark, Ohio.

Reunion Neuroscience stock logo

Reunion Neuroscience TSE:REUN

Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company, develops therapeutic solutions for mental health conditions in North America. The company's lead asset includes RE104, a clinical-stage serotonergic psychedelic therapeutic product for antidepressant applications. It is also developing the RE200 series, which comprises molecules that are structurally designed to be similar to classical psychedelics with selective potency at the target serotonin 2A receptor (5HT2A) for potential chronic treatment in various patient populations and indications. The company was formerly known as Field Trip Health Ltd. Reunion Neuroscience Inc. was founded in 2008 and is headquartered in Toronto, Canada.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas